ATTH Insider Trading Activity and SEC Form 4 Filings
ATTH insider trading summary
No open-market insider purchases or sales of Atlas Therapeutics Corp (ATTH) have been reported on SEC Form 4 in the past 12 months.
Latest ATTH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 10, 2011 | Janine DiVenuto | 10% Owner | Buy | $200 (1,000 @ $0.20) |
| Oct 6, 2011 | Janine DiVenuto | 10% Owner | Buy | $480 (2,000 @ $0.24) |
| Oct 3, 2011 | Janine DiVenuto | 10% Owner | Buy | $145 (500 @ $0.29) |
| Oct 3, 2011 | Janine DiVenuto | 10% Owner | Buy | $128 (400 @ $0.32) |
| Oct 3, 2011 | Janine DiVenuto | 10% Owner | Buy | $210 (700 @ $0.30) |
| Sep 30, 2011 | Janine DiVenuto | 10% Owner | Buy | $128 (400 @ $0.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.